{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T06:03:08Z","timestamp":1781071388394,"version":"3.54.1"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Aim of the Study<\/jats:title>\n                    <jats:p>To observe the efficacy and safety of CQE in rapidly alleviating inflammatory activity in UC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>CQE extracts were analyzed by UHPLC\u2013Q Exactive Orbitrap\u2013HRMS. This study used a self-controlled design before and after treatment. A total of 114 UC patients were included and treated with traditional rectal enema administration of CQE. Among them, 107 patients completed the treatment, and 101 patients with complete clinical and laboratory data were included in the final analysis. The primary clinical intestinal symptoms, mucosal endoscopic and pathological changes, laboratory indicators, quality of life scores, and adverse reactions were compared before and after 14 days of enema treatment. A historical comparison was made with previous studies. The expression of intestinal tight junction proteins in the colons of UC patients during active periods was detected using Quantitative Real-time PCR (RT-qPCR) and Western blot (WB).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The main compounds in CQE were identified, including Gallic acid, Matrine, Oxysophocarpine, Ellagic acid, Prim-O-glucosylcimifugin, Cytisinicline, Danshensu, Protocatechuic acid, Cimifugin, Salvianolic acid A Cytisinicline, Indigo, Indirubin, Tryptanthrin and others. The primary endpoint, defined as the change in modified Mayo score, showed a significant improvement after 14 days of CQE treatment (\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001). The clinical response rate was 94.06% (95\/101), and the clinical remission rate was 66.34% (67\/101). The endoscopic mucosal healing rate was 76.24% (77\/101), and the histological remission rate was 38.61% (39\/101). Compared to before treatment, post-treatment scores for clinical intestinal symptoms, Mayo endoscopic scores (MES), Geboes index, fecal calprotectin (FC), and fecal occult blood test (OB) were significantly reduced (\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001). The UCEIS score for the distal rectum and sigmoid colon showed more improvement than the proximal colon (\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.01). Hemoglobin (HGB), albumin (ALB), and quality of life scores increased (\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.05), while liver and kidney function indicators showed no abnormal elevations after treatment (\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.05). Compared to historical data from previous studies using steroids and biologics, CQE significantly improved clinical and endoscopic remission rates. RT-qPCR and WB results demonstrated that the herbal enema helps repair the intestinal mucosal barrier in UC patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CQE can rapidly alleviate inflammatory activity in UC within 14 days and improve patients\u2019 quality of life, with a low incidence of adverse events.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1776775","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T05:41:34Z","timestamp":1781070094000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of compound Qingdai enema in rapidly alleviating inflammatory activity in ulcerative colitis: a prospective study"],"prefix":"10.3389","volume":"17","author":[{"given":"Yao","family":"Huang","sequence":"first","affiliation":[{"name":"The First School of Clinical Medicine, Zhejiang Chinese Medical University","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DanPing","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine)","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyan","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of General Medicine, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine)","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YiWen","family":"Fang","sequence":"additional","affiliation":[{"name":"Medical Department for Senior Cadres, The Third Affiliated Hospital of Zhejiang Chinese Medical University (Zhongshan Hospital of Zhejiang Province)","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SiHui","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Yuyao Traditional Chinese Medicine Hospital","place":["Ningbo, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ChunLi","family":"Zhang","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine)","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Liu","sequence":"additional","affiliation":[{"name":"Clinical Evaluation Center, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine)","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"376","DOI":"10.16252\/j.cnki.issn1004-0501-2005.04.013","article-title":"Literature analysis of therapeutic research on ulcerative colitis in China","author":"Chen","year":"2005","journal-title":"Sichuan Med. J."},{"key":"B2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/ueg2.12515","article-title":"Rapidly achieving clinical remission in ulcerative colitis indicates better endoscopic and histological outcomes","volume":"12","author":"Chen","year":"2024","journal-title":"United Eur. Gastro. J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12876-020-01301-3","article-title":"Ischemic colitis induced by indigo naturalis in a patient with ulcerative colitis: a case report","volume":"20","author":"Cho","year":"2020","journal-title":"BMC Gastro."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/j.cgh.2017.02.016","article-title":"Histologic normalization occurs in ulcerative colitis and is associated with improved clinical outcomes","volume":"15","author":"Christensen","year":"2017","journal-title":"Clin. Gastro. Hepatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/apt.15662","article-title":"Review article: faecal calprotectin and histologic remission in ulcerative colitis","volume":"51","author":"D'Amico","year":"2020","journal-title":"Aliment. Pharmacol. and Ther."},{"key":"B6","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1053\/j.gastro.2006.12.038","article-title":"A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis","volume":"132","author":"D'Haens","year":"2007","journal-title":"Gastroenterology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJMoa1215734","article-title":"Vedolizumab as induction and maintenance therapy for ulcerative colitis","volume":"369","author":"Feagan","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/1751-2980.12546","article-title":"Clinical, endoscopic and histological correlation and measures of association in ulcerative colitis","volume":"18","author":"Flux\u00e1","year":"2017","journal-title":"J. Digestive Diseases"},{"key":"B9","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/ajg.2011.70","article-title":"Glucocorticosteroid therapy in inflammatory bowel disease: systematic review and meta-analysis","volume":"106","author":"Ford","year":"2011","journal-title":"Am. Journal Gastroenterology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1136\/gut.47.3.404","article-title":"A reproducible grading scale for histological assessment of inflammation in ulcerative colitis","volume":"47","author":"Geboes","year":"2000","journal-title":"Gut"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1007\/s10620-021-07178-w","article-title":"Patient-reported outcome and clinical scores are equally accurate in predicting mucosal healing in ulcerative colitis: a prospective study","volume":"67","author":"Golovics","year":"2022","journal-title":"Dig. Dis. Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.jep.2011.08.057","article-title":"Efficacy and safety of fufangkushen colon-coated capsule in the treatment of ulcerative colitis compared with mesalazine: a double-blinded and randomized study","volume":"141","author":"Gong","year":"2012","journal-title":"J. Ethnopharmacology"},{"key":"B12","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0016-5085(89)80080-0","article-title":"A new measure of health status for clinical trials in inflammatory bowel disease","volume":"96","author":"Guyatt","year":"1989","journal-title":"Gastroenterology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1136\/gut.2004.056358","article-title":"Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitis","volume":"54","author":"Higgins","year":"2005","journal-title":"Gut"},{"key":"B14","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3748\/wjg.v8.i1.158","article-title":"An analysis of 10218 ulcerative colitis cases in China","volume":"8","author":"Jiang","year":"2002","journal-title":"World Journal Gastroenterology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"176318","DOI":"10.1016\/j.ejphar.2024.176318","article-title":"Sophocarpine alleviates intestinal fibrosis via inhibition of inflammation and fibroblast into myofibroblast transition by targeting the Sirt1\/p65 signaling axis","volume":"967","author":"Jiang","year":"2024","journal-title":"Eur. Journal Pharmacology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"E568","DOI":"10.1055\/a-0869-7619","article-title":"Relationship between endoscopic mucosal healing and histologic inflammation during remission maintenance phase in ulcerative colitis: a retrospective study","volume":"7","author":"Kanazawa","year":"2019","journal-title":"Endosc. International Open"},{"key":"B17","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3892\/etm.2023.11811Naganuma","article-title":"Polygonum tinctorium leaf extract ameliorates high-fat diet-induced intestinal epithelial damage in mice","volume":"25","author":"Kawaguchi","year":"2023","journal-title":"Exp. Therapeutic Medicine"},{"key":"B18","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.cgh.2020.12.017","article-title":"Endoscopic assessment of inflammatory bowel disease activity in clinical trials","volume":"20","author":"Khanna","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s00535-022-01862-y","article-title":"A review on the current status and definitions of activity indices in inflammatory bowel disease: how to use indices for precise evaluation","volume":"57","author":"Kishi","year":"2022","journal-title":"J. Gastroenterol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S2468-1253(21)00377-0","article-title":"Efficacy and safety of biologics and small molecule drugs for patients with moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis","volume":"7","author":"Lasa","year":"2022","journal-title":"Lancet. Gastroenterol. and Hepatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1016\/j.cgh.2022.11.029","article-title":"Upadacitinib therapy reduces ulcerative colitis symptoms as early as day 1 of induction treatment","volume":"21","author":"Loftus","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"157433","DOI":"10.1016\/j.phymed.2025.157433","article-title":"Fufang danshen pill improves mitochondrial homeostasis by regulating the S100A9\/TLR4 axis to alleviate myocardial ischemia-reperfusion injury","volume":"148","author":"Lu","year":"2025","journal-title":"Phytomedicine"},{"key":"B22","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/ecco-jcc\/jjx008","article-title":"Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders","volume":"11","author":"Magro","year":"2017","journal-title":"J. Crohn's and Colitis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1093\/ecco-jcc\/jjv208","article-title":"Twice-daily budesonide 2-mg foam induces complete mucosal healing in patients with distal ulcerative colitis","volume":"10","author":"Naganuma","year":"2016","journal-title":"J. Crohns Colitis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet (London, Engl)."},{"key":"B24","doi-asserted-by":"publisher","first-page":"140564","DOI":"10.1016\/j.foodchem.2024.140564","article-title":"Non-targeted metabolomics and explainable artificial intelligence: effects of processing and color on coniferyl aldehyde levels in eucommiae cortex","volume":"460","author":"Pan","year":"2024","journal-title":"Food Chem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/ecco-jcc\/jjab178","article-title":"ECCO guidelines on therapeutics in ulcerative colitis: medical treatment","volume":"16","author":"Raine","year":"2022","journal-title":"J. Crohn's and Colitis"},{"key":"B40","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00384-025-04829-6","article-title":"Correlation of a clinical activity index in comparison to frequently measured laboratory values in inflammatory bowel disease","volume":"40","author":"Rapo","year":"2025","journal-title":"Int. J. Colorectal Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1136\/gut.2005.082909","article-title":"The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications","volume":"55","author":"Satsangi","year":"2006","journal-title":"Gut"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1093\/ecco-jcc\/jjaa041","article-title":"Time to symptom resolution in ulcerative colitis with multimatrix mesalazine treatment: a pooled analysis","volume":"14","author":"Schreiber","year":"2020","journal-title":"J. Crohn's and Colitis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1056\/NEJM198712243172603","article-title":"Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study","volume":"317","author":"Schroeder","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"100512","DOI":"10.1016\/j.medj.2024.09.001","article-title":"Responsiveness of different disease activity indices in moderate-to-severe ulcerative colitis","volume":"6","author":"Solitano","year":"2025","journal-title":"Med. (New York, N.Y.)"},{"key":"B30","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/ecco-jcc\/jju010","article-title":"Long-term efficacy and safety of azathioprine in ulcerative colitis","volume":"9","author":"Sood","year":"2015","journal-title":"J. Crohn's and Colitis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1136\/bmj.2.4947.1041","article-title":"Cortisone in ulcerative colitis; final report on a therapeutic trial","volume":"2","author":"Truelove","year":"1955","journal-title":"Br. Medical Journal"},{"key":"B32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/gut.43.1.29","article-title":"A simple clinical colitis activity index","volume":"43","author":"Walmsley","year":"1998","journal-title":"Gut"},{"key":"B33","doi-asserted-by":"publisher","first-page":"5551","DOI":"10.3390\/jcm10235551","article-title":"Treatment targets in ulcerative colitis: is it time for all In, including histology?","volume":"10","author":"Wetwittayakhlang","year":"2021","journal-title":"J. Clinical Medicine"},{"key":"B34","doi-asserted-by":"publisher","first-page":"832219","DOI":"10.3389\/fsurg.2022.832219","article-title":"The Mayo endoscopic score is a novel predictive indicator for malignant transformation in ulcerative colitis: a long-term Follow-Up multicenter study","volume":"9","author":"Xu","year":"2022","journal-title":"Front. Surg."},{"key":"B35","doi-asserted-by":"publisher","first-page":"114476","DOI":"10.1016\/j.fct.2024.114476","article-title":"The double-edged sword effect of indigo naturalis","volume":"185","author":"Xu","year":"2024","journal-title":"Food Chem. Toxicol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1095721","DOI":"10.3389\/fphar.2023.1095721","article-title":"Gallic acid ameliorates dextran sulfate sodium-induced ulcerative colitis in mice via inhibiting NLRP3 inflammasome","volume":"14","author":"Yu","year":"2023","journal-title":"Front. Pharmacol."},{"key":"B37","first-page":"38","article-title":"Clinical characteristics of 174 patients with ulcerative colitis","volume":"26","author":"Zheng","year":"2022","journal-title":"Chin. J. Laboratory Diagnosis"},{"key":"B38","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.intimp.2018.11.040","article-title":"Gallic acid improved inflammation via NF-\u03baB pathway in TNBS-Induced ulcerative colitis","volume":"67","author":"Zhu","year":"2019","journal-title":"Int. Immunopharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1776775\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T05:41:35Z","timestamp":1781070095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1776775\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":42,"alternative-id":["10.3389\/fphar.2026.1776775"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1776775","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"article-number":"1776775"}}